Evonik acquires METEX's methionine fermentation technology

enhance the biotechnical capability of Evonik to produce amino acidsuMuto promote the commercialization process of other alternative chemical process technologies developed by METEX
uMuare exploring further cooperation opportunitiesuMuGerman Winstart Industries Group to invest 45 million euros to acquire the French company METabolic EXplorer (METEX) of the methionine fermentation technology to further enhance its biotechnology capacity in amino acid productionThe acquisition agreement was signed in Paris on November 28, 2016 and includes the full content of METEX's methionine fermentation production technology, including patents, important bacterial strains, and the inoLaTM brandumu
The transaction also signed a reward license agreement for the transfer of certain patents to Evonik, allowing METEX to continue to use those patents in addition to methionine-related activitiesIn addition, the two companies plan to explore the possibility of co-development and development of the use of biotechnology to produce amino acidsThe technology transfer service agreement is for a period of two yearsMETEX believes the acquisition highlights the importance of its alternative technologies while enhancing their ability to commercialize other technologiesumu
The technology of fermentation to produce amino acids is very important for Evonik's sustainable animal nutrition portfolio Over the past few years, Evonik has continuously increased the productivity of Biolys ® (Lysine), ThreAMINO ® (Sumine) and TrypAMINO ® (Trypamino) (trypnonine) and recently added Valamino ® (proline) to its portfolio umu
　　"Through the methionine fermentation process, METEX demonstrates superior research and development capabilities and has been granted extensive patent protection," said Dr Emmanuel Auer, head of Evonik's animal nutrition line "
uMu " We have proven that the fermentation method of producing methionine is a potential alternative to production that is well known in the industry We have demonstrated our leading technical strength to all our partner companies The acquisition funds will accelerate our development and marketing of other technologies, such as PDO (1,3-propylene glycol), MPG (1,2 propylene glycol) or other new high value-added modules," said Benjamin Gonzalez, CEO of METEX "METEX has many years of experience in fermentation production technology and styrogrades, " says Dr UMu Winstart Auer We firmly believe that practical biotechnology production process optimization solutions have great potential for development, whether in animal nutrition or in a wider range of other areas The acquisition will also improve and expand Evonik's technology portfolio in key innovation areas "
uMu in the metEX Gonzalez view, "amino acids are undoubtedly high value-added products." We are confident of developing more competitive solutions, not just in the production of methionine Optimizing the production process of the main raw materials for animal feed is one of our top priorities We look forward to working with Evonik for more constructive research and development "
uMu Evonik has more than 60 years of experience in producing essential amino acids, providing efficient and sustainable animal nutrition solutions to customers in more than 100 countries At present, Evonik is developing innovative feed additives other than amino acids to further enhance the efficacy of animal feed and create more value for customers Evonik's products and services in animal nutrition protect natural resources and reduce environmental impact, playing a vital role in the global production of healthy, economical foods umu
　　Founded in 1999 and headquartered in Clermont-Ferrand, France, METEX is a bio-based biochemical company dedicated to the development of biotechnology processes, products widely used in everyday products such as textile fibers and feed additives In the future, METEX will focus on developing environmentally friendly production processes for the consumer goods industry to meet consumer demand for sustainable production umu
　　Company Information uMu Evonik is an innovative industrial group from Germany, our core business - specialty chemicals in the world leader Improving business profitability and maintaining continued growth in corporate value are the core strategies of Evonik We combine business with global trends, namely health, nutrition, resource efficiency, globalization Evonik's development benefits from its innovative strength and integrated technology platform Evonik operates in more than 100 countries around the world In fiscal 2015, Evonik generated sales of approximately EUR 13.5 billion and operating profit (ebitda, interest, tax, depreciation and amortisation) of EUR 2.47 billion umu
　　Evonik Has been producing specialty chemicals in Greater China since the late 1970s, including Chinese mainland, Hong Kong and Taiwan, and has extensive operations in the region since before Evonik Greater China is one of the driving forces for global economic growth and is constantly striving to achieve continued growth in greater China Evonik Greater China now employs approximately 3,000 people and generated sales of more than 1.3 billion euros in 2015 uMu enhance the biotechnical capability of Evonik to produce amino acids uMu to promote the commercialization of other alternative chemical process technologies developed by METEX
uMu both sides are exploring further cooperation opportunities uMu German Evonik Industrial Group to invest 45 million euros to acquire the methioc EXplorer of France(METEX) of the methionine fermentation technology to enhance its production of amino acids The acquisition agreement was signed in Paris on November 28, 2016 and includes the full content of METEX's methionine fermentation production technology, including patents, important bacterial strains, and the inoLaTM brand umu
　　The transaction also signed a reward license agreement for the transfer of certain patents to Evonik, allowing METEX to continue to use those patents in addition to methionine-related activities In addition, the two companies plan to explore the possibility of co-development and development of the use of biotechnology to produce amino acids The technology transfer service agreement is for a period of two years METEX believes the acquisition highlights the importance of its alternative technologies while enhancing their ability to commercialize other technologies umu
　　The technology of fermentation to produce amino acids is very important for Evonik's sustainable animal nutrition portfolio Over the past few years, Evonik has continuously increased the productivity of Biolys ® (Lysine), ThreAMINO ® (Sumine) and TrypAMINO ® (Trypamino) (trypnonine) and recently added Valamino ® (proline) to its portfolio umu
　　"Through the methionine fermentation process, METEX demonstrates superior research and development capabilities and has been granted extensive patent protection," said Dr Emmanuel Auer, head of Evonik's animal nutrition line "
uMu " We have proven that the fermentation method of producing methionine is a potential alternative to production that is well known in the industry We have demonstrated our leading technical strength to all our partner companies The acquisition funds will accelerate our development and marketing of other technologies, such as PDO (1,3-propylene glycol), MPG (1,2 propylene glycol) or other new high value-added modules," said Benjamin Gonzalez, CEO of METEX "METEX has many years of experience in fermentation production technology and styrogrades, " says Dr UMu Winstart Auer We firmly believe that practical biotechnology production process optimization solutions have great potential for development, whether in animal nutrition or in a wider range of other areas The acquisition will also improve and expand Evonik's technology portfolio in key innovation areas "
uMu in the metEX Gonzalez view, "amino acids are undoubtedly high value-added products." We are confident of developing more competitive solutions, not just in the production of methionine Optimizing the production process of the main raw materials for animal feed is one of our top priorities We look forward to working with Evonik for more constructive research and development "
uMu Evonik has more than 60 years of experience in producing essential amino acids, providing efficient and sustainable animal nutrition solutions to customers in more than 100 countries At present, Evonik is developing innovative feed additives other than amino acids to further enhance the efficacy of animal feed and create more value for customers Evonik's products and services in animal nutrition protect natural resources and reduce environmental impact, playing a vital role in the global production of healthy, economical foods umu
　　Founded in 1999 and headquartered in Clermont-Ferrand, France, METEX is a bio-based biochemical company dedicated to the development of biotechnology processes, products widely used in everyday products such as textile fibers and feed additives In the future, METEX will focus on developing environmentally friendly production processes for the consumer goods industry to meet consumer demand for sustainable production umu
　　Company Information uMu Evonik is an innovative industrial group from Germany, our core business - specialty chemicals in the world leader Improving business profitability and maintaining continued growth in corporate value are the core strategies of Evonik We combine business with global trends, namely health, nutrition, resource efficiency, globalization Evonik's development benefits from its innovative strength and integrated technology platform Evonik operates in more than 100 countries around the world In fiscal 2015, Evonik generated sales of approximately EUR 13.5 billion and operating profit (ebitda, interest, tax, depreciation and amortisation) of EUR 2.47 billion umu
　　Evonik Has been producing specialty chemicals in Greater China since the late 1970s, including Chinese mainland, Hong Kong and Taiwan, and has extensive operations in the region since before Evonik Greater China is one of the driving forces for global economic growth and is constantly striving to achieve continued growth in greater China Evonik Greater China now employs approximately 3,000 people and generated sales of more than 1.3 billion euros in 2015 uMu